Your session is about to expire
← Back to Search
In-House Developed VR Platform - AMD, DR, Glaucoma for Visual Impairment
Study Summary
This trial uses virtual reality to simulate different types and severities of visual impairments in order to provide a safe, controllable, and repeatable environment for development and preliminary testing of electronic travel aids.
- Visual Impairment
- Diabetic Retinopathy
- Age-Related Macular Degeneration
- Glaucoma
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What is the ceiling for participants in this investigation?
"Affirmative, clinicaltrials.gov contains proof that this medical trial is currently seeking volunteers and was initially posted on October 24th 2021. The most recent amendment took place on October 6th 2022 with the aim of enrolling 446 patients from one site."
Am I eligible to take part in this research endeavor?
"This research project requires the recruitment of 446 glaucoma patients between 18 and 80 years old. Furthermore, potential participants must meet general inclusion criteria as well as possess some form of visual impairment regardless of gender or severity of disease."
Is the age range for this research restricted to individuals over 55?
"As specified in the study's requirements for enrolment, individuals must be between 18 and 80 years old to take part."
Are any new applicants still being accepted into this investigation?
"Correct. From clinicaltrials.gov, it can be inferred that this medical research has commenced recruitment and is searching for 446 participants from a single site. This project was initially posted on October 24th 2021 with its last update being on the tenth of October 2022."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
How many prior treatments have patients received?
Why did patients apply to this trial?
What questions have other patients asked about this trial?
Share this study with friends
Copy Link
Messenger